Growth Metrics

Zevra Therapeutics (ZVRA) Amortization - Intangibles (2023 - 2025)

Historic Amortization - Intangibles for Zevra Therapeutics (ZVRA) over the last 3 years, with Q3 2025 value amounting to $315000.0.

  • Zevra Therapeutics' Amortization - Intangibles fell 7961.17% to $315000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 424.78%. This contributed to the annual value of $6.2 million for FY2024, which is 70764.25% up from last year.
  • As of Q3 2025, Zevra Therapeutics' Amortization - Intangibles stood at $315000.0, which was down 7961.17% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Zevra Therapeutics' Amortization - Intangibles ranged from a high of $1.6 million in Q4 2024 and a low of $315000.0 during Q3 2025
  • Moreover, its 3-year median value for Amortization - Intangibles was $1.5 million (2024), whereas its average is $1.3 million.
  • Its Amortization - Intangibles has fluctuated over the past 5 years, first skyrocketed by 10932.64% in 2024, then plummeted by 7961.17% in 2025.
  • Over the past 3 years, Zevra Therapeutics' Amortization - Intangibles (Quarter) stood at $772000.0 in 2023, then skyrocketed by 109.33% to $1.6 million in 2024, then plummeted by 80.51% to $315000.0 in 2025.
  • Its Amortization - Intangibles was $315000.0 in Q3 2025, compared to $1.6 million in Q2 2025 and $1.6 million in Q1 2025.